| # | Drug | Count |
|---|---|---|
| 0 | PANTOPRAZOLE | 38 |
| 1 | TACROLIMUS | 35 |
| 2 | FUROSEMIDE | 34 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 34 |
| 4 | TACROLIMUS OINTMENT 0.1% | 34 |
| 5 | DARBEPOETIN ALFA | 28 |
| 6 | METHOTREXATE SODIUM | 27 |
| 7 | SODIUM BICARBONATE | 27 |
| 8 | SODIUM BICARBONATE INJECTION, | 27 |
| 9 | SODIUM BICARBONATE, INJECTION | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0040 |
| 1 | BENZOCAINE AND MENTHOL | 1 | 0.0038 |
| 2 | PIMECROLIMUS | 5 | 0.0028 |
| 3 | CHLORAMBUCIL | 10 | 0.0025 |
| 4 | PSYLLIUM HUSK | 3 | 0.0022 |
| 5 | FLUVASTATIN SODIUM | 9 | 0.0020 |
| 6 | RITUXIMAB-ABBS | 10 | 0.0020 |
| 7 | AMPHOTERICIN B | 22 | 0.0017 |
| 8 | CETYLPYRIDINIUM CHLORIDE | 1 | 0.0015 |
| 9 | RESLIZUMAB | 1 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 51 |
| 1 | Corticosteroid [EPC] | 45 |
| 2 | Loop Diuretic [EPC] | 36 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 30 |
| 4 | beta-Adrenergic Blocker [EPC] | 30 |
| 5 | Erythropoiesis-stimulating Agent [EPC] | 28 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 26 |
| 7 | Proton Pump Inhibitor [EPC] | 26 |
| 8 | alpha-Adrenergic Blocker [EPC] | 25 |
| 9 | Polyene Antifungal [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 22 | 0.0017 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 23 | 0.0010 |
| 4 | Thyroid Stimulating Hormone [EPC] | 1 | 0.0010 |
| 5 | Polyene Antifungal [EPC] | 24 | 0.0006 |
| 6 | Erythropoiesis-stimulating Agent [EPC] | 28 | 0.0005 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 8 | GLP-2 Analog [EPC] | 6 | 0.0004 |
| 9 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |